G
G. Poston
Researcher at Royal Liverpool and Broadgreen University Hospital NHS Trust
Publications - 15
Citations - 724
G. Poston is an academic researcher from Royal Liverpool and Broadgreen University Hospital NHS Trust. The author has contributed to research in topics: Radiofrequency ablation & Carcinoid syndrome. The author has an hindex of 8, co-authored 15 publications receiving 622 citations.
Papers
More filters
Journal ArticleDOI
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
T. Ruers,Cornelis J. A. Punt,F. van Coevorden,Jean-Pierre E. N. Pierie,I. Borel-Rinkes,Jonathan A. Ledermann,G. Poston,Wolf O. Bechstein,M.A. Lentz,Murielle Mauer,E. Van Cutsem,Manfred P. Lutz,Bernard Nordlinger +12 more
TL;DR: The study met the primary end point on 30-month OS; however, the results in the control arm were in the same range; at present, the ultimate effect of RFA on OS remains uncertain.
Journal ArticleDOI
6010 POSTER DISCUSSION Radiofrequency Ablation Combined With Systemic Treatment Versus Systemic Treatment Alone in Patients With Non- Resectable Colorectal Liver Metastases: a Randomized EORTC Intergroup Phase II Study (EORTC 40004)
T.J.M. Ruers,C.J.A. Punt,F. van Coevorden,Jonathan A. Ledermann,G. Poston,Wolf O. Bechstein,M.A. Lentz,M. Mauei,Manfred P. Lutz,Bernard Nordlinger +9 more
TL;DR: This is the first randomized study on the efficacy of RFA and the study met the primary end point on 30-month OS; however, the results in the control arm were in the same range.
Journal ArticleDOI
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
René Adam,Daniel G. Haller,G. Poston,Jean-Luc Raoul,Jean-Philippe Spano,Josep Tabernero,E. Van Cutsem +6 more
TL;DR: The objectives of this expert conference were to review the different options, the available prognostic or predictive factors to optimally guide the treatment of metastatic colorectal cancer.
Journal ArticleDOI
O-018Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)
T.J.M. Ruers,C.J.A. Punt,F. van Coevorden,J.-P. Pierie,I. H. M. Borel Rinkes,Jonathan A. Ledermann,G. Poston,Wolf O. Bechstein,M.A. Lentz,Murielle Mauer,E. Van Cutsem,Manfred P. Lutz,B. Nordlinger +12 more
Journal ArticleDOI
Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
Rebecca Dobson,Daniel J. Cuthbertson,Julia Jones,Juan W. Valle,Brian G. Keevil,Carrie Chadwick,G. Poston,Malcolm I. Burgess +7 more
TL;DR: The Westberg score appears to be the most optimal scoring system for use in screening of CHD whereas the more complex scoring systems are more suited to the patient with established disease who may require surgical intervention.